« Back
Home /
A2M Peptide - N-terminal region (AAP59224)

A2M Peptide - N-terminal region (AAP59224)

Item no.	AAP59224
Manufacturer	AVIVA Systems Biology
Amount	100ug
Category	Oncology Neuroscience Neural Lineage Markers Neuroinflammation Metabolism Glucose Homeostasis Cholesterol & Lipid Metabolism Neural Transcription Factors Molecular Targets for Neuroscience Targets for Rodent Neurosciences Aging & Neurological Disorders Neural Signaling Peptides & Proteins Western Blot Peptides By Organ Testicular & Prostate Cancer
Type	Peptides
Format	Lyophilized powder
Applications	WB
Specific against	Human (Homo sapiens)
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	CPAMD5, DKFZp779B086, FWP007, S863-7
Similar products	A2M
Available
Description	This is a synthetic peptide designed for use in combination with anti-A2M Antibody (ARP59224_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Gene symbol	A2M
Protein size	1474
Molecular weight	161kDa
Product format	Lyophilized powder
Gene id	2
Reconstitution and storage	Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles.
Partner proteins	ADAM19, ADAMTS1, AMBP, ANXA6, APOE, ATF7IP, B2M, C11orf58, CELA1, CTSB, CTSE, HSPA5, IL10, IL1B, KLK2, KLK3, LCAT, LEP, LRP1, LYZ, MMP2, MYOC, NGF, PAEP, PDGFA, PDGFB, SHBG, TGFBI, STAT3, ADAMTS1, AMBP, ANXA7, APOE, B2M, C11orf58, CDC42, CDK2AP2, CDKN1A, CPB2, GEM, GRB2, H2AFX, HMOX2, HSPA5, IL10, IL4, KLK13, KLK3, LCAT, LEP, LRP1, MMP2, NGF, NUDT21, PAEP, RAP1B, RPP14, SEPT8, SMN1, TGIF1, TK1, TNFRSF14, TSC22D1, TTR, UFD1L
Description of target	Alpha-2-macroglobulin is a protease inhibitor and cytokine transporter. It inhibits many proteases, including trypsin, thrombin and collagenase. A2M is implicated in Alzheimer disease (AD) due to its ability to mediate the clearance and degradation of A-beta, the major component of beta-amyloid deposits.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

AAP59224-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 100ug

available

Delivery expected until 10/30/2025

Express Delivery: Save 20 days

Compare

Add to wishlist

Get an offer